269: Biotech layoffs, eye drug drama, & gene therapy milestones

First, we discuss how some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

Episode metadata supplied by the publisher feed · Published Aug 3, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

269: Biotech layoffs, eye drug drama, & gene therapy milestones

0:00 37:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 37 minutes long.

When was this The Readout Loud episode published?

This episode was published on August 3, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!